mt-7716

Description: MT-7716 (also known as W-212393) is a novel, potent and selective non-peptide nociceptin receptor (NOP) agonist with the potential to be used for treatment of alcohol abuse and relapse prevention. The effects of MT-7716 (0.3 and 1 mg/kg; PO) on alcohol self-administration were determined 2 weeks following dependence induction, when baseline self-administration was restored. Effects of MT-7716 on stress-induced reinstatement were tested in separate cohorts of rats, 1 and 3 weeks post-withdrawal. MT-7716 reduced alcohol self-administration and stress-induced reinstatement of alcohol seeking in post-dependent rats, but was ineffective in non-dependent animals. Moreover, the prevention of stress-induced reinstatement by MT-7716 was more pronounced at 3 weeks post-dependence. The results further confirm treatment target potential for the NOP receptor and identify non-peptide NOP agonists as promising potential treatment drugs for alcohol abuse and relapse prevention. The findings also support dysregulation of the N/OFQ system as a factor in alcohol seeking and reinforcement.

References: Addict Biol. 2015 Jul; 20(4):643-51.

Related CAS : 610323-32-5 (free base); 1215859-93-0 (HCl)